"Have you ever considered joining a clinical trial? You may benefit from new treatments that are not otherwise available to the public while improving the lives of future generations. As a patient at Paramount Medical Research, our clinical trials are coordinated by experienced registered nurses. You can expect exceptional care by our trained, dedicated staff. Compensation for time and travel is generally available. Dr. Isam A. Diab, M.D. specializes in rheumatology and internal medicine. He has conducted clinical research for 20 years, while growing his private practice into one of the largest within the United States by collaborating with over 75 private practices in the Cleveland Area."

During the past decade, Paramount Medical Research & Consulting, LLC conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 31 clinical trials were completed, i.e. on average, 70.5% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 18 clinical trials were completed. i.e. 78.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paramount Medical Research & Consulting, LLC" #1 sponsor was "Eli Lilly and Company" with 15 trials, followed by "Bristol-Myers Squibb" with 9 trials sponsored, "Pfizer" with 9 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paramount Medical Research & Consulting, LLC" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator, "BARC Global Central Laboratory" with 1 trials as a collaborator and "Bilcare Global Clinical Supplies" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Paramount Medical Research & Consulting, LLC" are "Rheumatoid Arthritis" (14 trials), "Systemic Lupus Erythematosus" (10 trials), "Psoriatic Arthritis" (6 trials), "Lupus Erythematosus, Systemic" (5 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Paramount Medical Research & Consulting, LLC" in a lesser frequency.

Most popular intervention types in "Paramount Medical Research & Consulting, LLC" are "Drug" (54 trials), "Other" (10 trials), "Biological" (5 trials), "Diagnostic Test" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Baricitinib" (7 trials), "Filgotinib" (5 trials), "Methotrexate" (5 trials) and "Placebo to match filgotinib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Paramount Medical Research & Consulting, LLC" are 60 trials for "All" genders.

Currently, there are NaN active trials in "Paramount Medical Research & Consulting, LLC". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 25 completed trials in Paramount Medical Research & Consulting, LLC, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Paramount Medical Research & Consulting, LLC, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 0 trials that are defined as “Not Applicable".